4/A//SEC Filing
VENTRUS BIOSCIENCES INC 4/A
Accession 0001144204-14-015529
$ASMBCIK 0001426800operating
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:29 PM ET
Size
9.3 KB
Accession
0001144204-14-015529
Insider Transaction Report
Form 4/AAmended
BARRETT DAVID JONATHAN
Chief Financial Officer
Transactions
- Award
Stock Options (right to buy)
2014-01-15+213,000→ 213,000 totalExercise: $3.81Exp: 2024-01-15→ Common Stock (213,000 underlying)
Holdings
- 50,000
Phantom Stock
→ Common Stock (50,000 underlying) - 150,000
Restricted Stock Units
Exp: 2016-06-30→ Common Stock (200,000 underlying)
Footnotes (6)
- [F1]The options vest 1/3 on 1/15/2015, and the remaining 2/3 will vest in equal installments on the second and third anniversaries after 1/15/2014.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units vest in four equal amounts (25% each) as follows: 25% on the date of grant and 25% when the 20 trading day volume weighted average price of the Issuer's common stock equals or exceeds $4.15, $5.15 and $6.15. The unvested restricted stock units expire on June 30, 2016 if a vesting threshold has not been met by that date.
- [F4]Upon the immediate vesting on April 5, 2013 of 50,000 restricted stock units granted to the reporting person on April 5, 2013, the reporting person elected to defer the receipt of those 50,000 shares of common stock, resulting in the accrual to his phantom stock account of 50,000 shares of phantom stock.
- [F5]Each share of phantom stock represents the right to receive one share of the Issuer's common stock.
- [F6]The phantom stock becomes payable on the earliest to occur of (a) termination of employment, (b) a change in control of the Issuer, or (c) April 1, 2015.
Documents
Issuer
VENTRUS BIOSCIENCES INC
CIK 0001426800
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001426800
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:29 PM ET
- Size
- 9.3 KB